Healthcare

Neuroprotection Market to Expand at a Modest CAGR of 8.2% During the Forecast Period between 2017 and 2025

Press Release

Neuroprotection Market: Snapshot

The market for Neuroprotection is expected to grow at steady growth rate during the forecast period largely attributed due to increasing drug development in the pharmaceutical and biotechnology industry along with increasing patient population pool, growing incidences of CNS diseases, increasing awareness, increased demand for more target specific drug treatment for Neurodegenerative diseases along with favorable government regulations. The other factors responsible for the growth the market include increasing healthcare infrastructure, increasing economic stability in developing economies, increasing participation of major market players in in developing economies such as Latin America and Middle East & Africa. The North America region in Neuroprotection market is anticipated to hold major market share along with Europe region during the forecast period. The region are expected to grow moderately in comparison to Asia Pacific region during the forecast period whereas, primarily due to the effect of pricing pressure due to increased competition among leading brands, increase of generic products and growing number of regional players who are able to provide products at much lower prices. However, new product launch and robust pipeline are expected to enter Neuroprotection market, which are likely to increase future growth and demand of the Neuroprotection.

Obtain Report Details @

https://www.transparencymarketresearch.com/neuroprotection-market.html

Transparency Market Research estimates that the global Neuroprotection market will increase at a CAGR of 8.2% during the forecast period between 2017 and 2025. Driven by the growing healthcare industry, increasing use of Neuroprotection in cosmetics, government initiatives, and rising ageing population, the market valued at US$ 23,170.6 Mn in 2016 in terms of revenue.

Based on product type the Neuroprotection market during 2016, the free radical trapping agents held a prominent share of approximately 36.4% of the global Neuroprotection market share. The segment is expected to expand at an equitable growth during the forecast period as equated to the other product types. The high growth segment in Neuroprotection drug class was the free radical trapping agents (Antioxidants) exhibiting a CAGR of 9.0% during the forecast period. The high growth is due to the increasing use antioxidants for treatment of neurodegenerative diseases such as Alzheimer’s and free radical trapping agents are more efficient in preventing further degradation of neural cells. Increasing demand for more efficient drug, increasing use of herbal extract free radical trapping agents such as cannabidiol, Vitamins E and C, and increasing research and development is expected to drive the market during the forecast period. Companies such as Biogen, Inc. have a robust product portfolio for treatment of neurological disorders such as, in June,2017, The European Commission (EC) has allowed an authorization of marketing to Biogen’s drug SPINRAZA (nusinersen), for treating 5q spinal muscular atrophy (SMA) in the European Union (EU).

Request for Sample Copy of Report @

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=40553

Based on Application the Neuroprotection market has been segment into: prevention, and treatment. The treatment application is expected to expand at a higher CAGR during the period 2017-2025, whereas the prevention is expected to grow at a lower rate during the forecast period. Increasing demand for highly efficient drug delivery module is expected to drive the market growth.

Request Report Brochure @

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=40553

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: www.transparencymarketresearch.com